Year None202320222021202020192018201720162015201420132012 06.02.2022 Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 05.17.2022 Iveric Bio to Present at the UBS Global Healthcare Conference 2022 05.16.2022 Iveric Bio to Participate in the H.C. Wainwright Global Investment Conference 05.04.2022 Iveric Bio Reports First Quarter 2022 Operational Highlights and Financial Results 05.04.2022 Iveric Bio Announces Presentation of Post-Hoc Analysis from GATHER1 Clinical Trial of Zimura® in Patients with Geographic Atrophy 05.03.2022 Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 04.27.2022 Iveric Bio to Report First Quarter 2022 Financial Results and Host Conference Call on Wednesday, May 4, 2022 04.26.2022 Iveric Bio to Participate in the B. Riley Securities' 2022 Virtual Neuro & Ophthalmology Conference 04.01.2022 Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 03.02.2022 Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Pagination First page « first Previous page ‹ previous Page 1 Page 2 Page 3 Page 4 Current page 5 Page 6 Page 7 Page 8 Page 9 … Next page next › Last page last »
